Sodium Butyrate Ameliorates Type 2 Diabetes-Related Sarcopenia Through IL-33-Independent ILC2s/IL-13/STAT3 Signaling Pathway
Yuan Cao,1– 3 Yulin Li,1– 3 Wenqiang Han,1– 3 Xu Jia,1– 3 Ping Zhu,1– 3 Bin Wei,4 Xiaoyan Cong,5,6 Zhihao Wang7,8 1Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, Jinan, Peop...
Main Authors: | Cao Y, Li Y, Han W, Jia X, Zhu P, Wei B, Cong X, Wang Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-01-01
|
Series: | Journal of Inflammation Research |
Subjects: | |
Online Access: | https://www.dovepress.com/sodium-butyrate-ameliorates-type-2-diabetes-related-sarcopenia-through-peer-reviewed-fulltext-article-JIR |
Similar Items
-
Osthole alleviates food allergy by blocking IL-33/ST2 pathway and targeting ILC2-CD4+T response
by: Lei Wang, et al.
Published: (2023-09-01) -
IL-33 induces NF-κB activation in ILC2 that can be suppressed by in vivo and ex vivo 17β-estradiol
by: Shubhanshi Trivedi, et al.
Published: (2022-11-01) -
IL-13Rα2 Regulates the IL-13/IFN-γ Balance during Innate Lymphoid Cell and Dendritic Cell Responses to Pox Viral Vector-Based Vaccination
by: Zheyi Li, et al.
Published: (2021-05-01) -
Hyperbaric oxygen augments susceptibility to C. difficile infection by impairing gut microbiota ability to stimulate the HIF-1α-IL-22 axis in ILC3
by: José L. Fachi, et al.
Published: (2024-12-01) -
ILC2s in skin disorders
by: Yasutomo Imai
Published: (2023-04-01)